These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8047771)

  • 21. Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group.
    Berardelli A; Formica A; Mercuri B; Abbruzzese G; Agnoli A; Agostino R; Caraceni T; Carella F; De Fazio G; De Grandis D
    Ital J Neurol Sci; 1993 Jun; 14(5):361-7. PubMed ID: 8354632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.
    Mauriello JA; Coniaris H; Haupt EJ
    Ophthalmology; 1987 Aug; 94(8):976-9. PubMed ID: 3658375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of botulinum toxin on ocular tissue.
    Smith H
    Nurs Times; 1995 Jan 25-31; 91(4):41-3. PubMed ID: 7862573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Botulinum-A toxin in the treatment of craniocervical muscle spasms: short- and long-term, local and systemic effects.
    Dutton JJ
    Surv Ophthalmol; 1996; 41(1):51-65. PubMed ID: 8827930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology.
    Giladi N; Meer J; Kidan C; Greenberg E; Gross B; Honigman S
    Isr J Med Sci; 1994 Nov; 30(11):816-9. PubMed ID: 7982770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of botulinum toxin in blepharospasm.
    Shorr N; Seiff SR; Kopelman J
    Am J Ophthalmol; 1985 May; 99(5):542-6. PubMed ID: 4003489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurology quiz. Idiopathic hemifacial spasm.
    Horne M
    Aust Fam Physician; 1994 Jul; 23(7):1366-8. PubMed ID: 8060285
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical use of botulinum toxin. National Institutes of Health Consensus Development Conference Statement, November 12-14, 1990.
    Arch Neurol; 1991 Dec; 48(12):1294-8. PubMed ID: 1845036
    [No Abstract]   [Full Text] [Related]  

  • 29. Time course of distant effects of local injections of botulinum toxin.
    Garner CG; Straube A; Witt TN; Gasser T; Oertel WH
    Mov Disord; 1993; 8(1):33-7. PubMed ID: 8380486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local side effects of botulinum toxin injections.
    Patrinely JR; Whiting AS; Anderson RL
    Adv Neurol; 1988; 49():493-500. PubMed ID: 3278553
    [No Abstract]   [Full Text] [Related]  

  • 31. A new botulinum toxin (Xeomin) for cervical dystonia and blepharospasm.
    Med Lett Drugs Ther; 2010 Nov; 52(1351):90-1. PubMed ID: 21068703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Who needs botulinum toxin?
    Pittar G; Dunlop DB; Dunlop C
    Med J Aust; 1988 Sep; 149(5):232-3. PubMed ID: 3045506
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm.
    Albanese A; Colosimo C; Carretta D; Dickmann A; Bentivoglio AR; Tonali P
    Eur Neurol; 1992; 32(2):112-7. PubMed ID: 1563461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study.
    Jankovic J; Orman J
    Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dystonia and headaches: clinical features and response to botulinum toxin therapy.
    Galvez-Jimenez N; Lampuri C; Patiño-Picirrillo R; Hargreave MJ; Hanson MR
    Adv Neurol; 2004; 94():321-8. PubMed ID: 14509690
    [No Abstract]   [Full Text] [Related]  

  • 36. Botulinum toxin therapy.
    Savino PJ; Maus M
    Neurol Clin; 1991 Feb; 9(1):205-24. PubMed ID: 2011110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Craniocervical dystonia and facial hemispasm: clinical and pharmacological characteristics of 52 patients].
    Astarloa R; Morales B; Peñafiel N; Rábano J; de Yébenes JG
    Rev Clin Esp; 1991 Nov; 189(7):320-4. PubMed ID: 1767088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulinum toxin in otolaryngology: a review of its actions and opportunities for use.
    Neuenschwander MC; Pribitkin EA; Sataloff RT
    Ear Nose Throat J; 2000 Oct; 79(10):788-9, 792, 794 passim. PubMed ID: 11055100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of blepharospasm and hemifacial spasm with botulinum A toxin].
    Dai Z
    Zhonghua Yan Ke Za Zhi; 1993 May; 29(3):144-5. PubMed ID: 8223038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum isn't just a poison anymore. Botulinum toxin in treatment of strabismus and essential blepharospasm.
    Cibis GW; Waeltermann J
    Mo Med; 1985 Mar; 82(3):145-7. PubMed ID: 3974563
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.